Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

Abroad (travel likely)RecruitingPHASE3

Conditions

T2DM · Diabete Type 2 · DM

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Celltrion, Seoul, South Korea